Abstract:Exosome-based liquid biopsy holds great potential in monitoring tumor progression. Current exosome detection biosensors rely on signal amplification strategies to improve sensitivity; however, these strategies pay little attention to manipulating the number of signal reporters, limiting the rational optimization of the biosensors. Here, we have developed a modularized surface-enhanced Raman spectroscopy (SERS) labeling strategy, where each Raman reporter is coupled with lysine as a signal-lysine module, and thus the number of Raman reporters can be precisely controlled by the modularized solid-phase peptide synthesis. Using this strategy, we screened out an optimum Raman biosensor for ultrasensitive exosome detection, with the limit of detection of 2.4 particles per microliter. This biosensor enables a successful detection of the tumor with an average diameter of approximately 3.55 mm, and thus enables successful surveillance of the postoperative tumor recurrence in mice models and distinguishing cancer patients from healthy subjects. Our work provides a de novo strategy to precisely amplify signals toward a myriad of biosensor-related medical applications.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acssensors.1c00890.Experimental details; preparation and characterization of exosomes (Figure S1); preparation and characterization of compound 1 (Figure S2); characterization of the EpCAM aptamer carrying single Raman reporter (Figure S3); detection of A549 cells derived exosomes by SERS EpCAM-aptasensors carrying single Raman reporter and SERS random sequence-sensors carrying single Raman reporter (Figure S4); mass spectra of signal amplified parts carrying (a) 5, (b) 8, and (c) 10 Raman reporters (Figure S5); gel electrophoresis image for EpCAM aptamer carrying eight Raman reporters (Figure S6); quantitative analysis of A549 cell-derived exosomes by ELISA (Figure S7); linear range of exosome detection in plasma by SERS EpCAM-aptasensors carrying eight Raman reporters (Figure S8); stability of the SERS EpCAM-aptasensors for plasma exosome detection (6.00 × 107/mL) in three consecutive weeks (Figure S9); and correlation of the SERS signal with the tumor size of NSCLC mice models (Figure S10). Tables S1–S5 (PDF)This article has not yet been cited by other publications.

Harnessing Spatiotemporal-Specific Tumorous Exosome Dynamics: Ultra-Sensitive Lanthanide Luminescence Detection Strategy Enabled by Exosomal Membrane Engineering for Melanoma Immunotherapy Monitoring

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and Mirnas

Homogenous Magneto-Fluorescent Nanosensor for Tumor-Derived Exosome Isolation and Analysis.

Label-Free Quantitative Detection of Tumor-Derived Exosomes through Surface Plasmon Resonance Imaging

Ultrasensitive Detection of Exosomes Using an Optical Microfiber Decorated with Plasmonic MoSe2-Supported Gold Nanorod Nanointerfaces

Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis

Engineered Exosomes-Based Photothermal Therapy with MRI/CT Imaging Guidance Enhances Anticancer Efficacy through Deep Tumor Nucleus Penetration

Ultrasensitive Exosome Detection by Modularized SERS Labeling for Postoperative Recurrence Surveillance

Nanozyme Sensor Array Plus Solvent-Mediated Signal Amplification Strategy For Ultrasensitive Ratiometric Fluorescence Detection Of Exosomal Proteins And Cancer Identification

Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence

Selective detection of exosomes by elemental labeling ICP-MS based on cholesterol-EpCAM aptamer proximity ligation mediated MNAzyme assembly

Target proteins-regulated DNA nanomachine-electroactive substance complexes enable separation-free electrochemical detection of clinical exosome

Emerging Advances of Detection Strategies for Tumor-Derived Exosomes

Exosome Isolation and Detection: From Microfluidic Chips to Nanoplasmonic Biosensor

A PLA-mediated transistor biosensor enables specific identification of tumor-derived exosomal PD-L1

High-Performance Detection of Exosomes Based on Synergistic Amplification of Amino-Functionalized Fe3O4 Nanoparticles and Two-Dimensional MXene Nanosheets

Accurate Cancer Screening and Prediction of PD-L1-Guided Immunotherapy Efficacy Using Quantum Dot Nanosphere Self-Assembly and Machine Learning

Thermophoretic Aggregation Imaging of Tumor-Derived Exosomes by CRISPR-Cas13a-Based Nanoprobes

Magnetic lanthanide sensor with self-ratiometric time-resolved luminescence for accurate detection of epithelial cancerous exosomes

Visual and Fluorescence Dual Mode Platform for Sensitive and Accurate Screening of Breast Carcinoma

Integral Multielement Signals by DNA-Programmed UCNP-AuNP Nanosatellite Assemblies for Ultrasensitive ICP-MS Detection of Exosomal Proteins and Cancer Identification